WS02.13 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)S.-Y.M. Liu, J.-Y. Deng,H.-H. Yan,M.-Y. Yang,C.-R. Xu,M.-Y. Zheng,B. Gan,X.-C. Zhang, H.-Y. Tu, J.-J. Yang, H.-J. Chen,B.-C. Wang, Y. Li,Q. Zhou, Y.-L. WuJournal of Thoracic Oncology（2023）引用 0|浏览6暂无评分关键词pembrolizumab,untreated advanced nsclc,sintilimabAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
